Affordable Access

Publisher Website

A study of release mechanisms of different ophthalmic drugs from erodible ocular inserts based on poly(ethylene oxide)

Authors
Journal
European Journal of Pharmaceutics and Biopharmaceutics
0939-6411
Publisher
Elsevier
Publication Date
Volume
54
Issue
2
Identifiers
DOI: 10.1016/s0939-6411(02)00086-3
Keywords
  • Release Mechanism
  • Ocular Insert
  • Poly(Ethylene Oxide)
  • Prednisolone
  • Oxytetracycline
  • Gentamicin
  • Ofloxacin
Disciplines
  • Medicine

Abstract

Abstract When topical controlled delivery of ophthalmic drugs is realised via erodible inserts, drug bioavailability is maximised, if release is controlled exclusively by insert erosion, since parallel mechanisms which increase the release rate, also increases the dose fraction cleared from the precorneal area by tear fluid draining. The respective contributions of diffusion and erosion to the release mechanism of different drugs, namely, prednisolone (PDS), oxytetracycline hydrochloride (OTH) and gentamicin sulfate (GTS), from erodible ocular inserts based on poly(ethylene oxide) (PEO) of molecular weight 400 or 900 kDa was determined by an in vitro technique adequate to predict the release mechanism in vivo. PDS and OTH were released with erosion-controlled kinetics. With therapeutic doses of these drugs in the inserts (0.3 mg, 1.5%), the possibility of a purely erosive mechanism was shown to rely upon drug–PEO molecular interactions, which limit drug diffusion in the swollen matrix. This was the case with OTH, for which strong interactions with PEO were measured, whereas some contribution from the parallel diffusive mechanism was evidenced for PDS, which showed weaker interactions with polymer. Such a contribution disappeared when the PDS concentration in the insert was increased to 6%, which suggested that the erosive mechanism is favoured by a drug concentration in the hydrated insert substantially higher than solubility. On the other hand, the release of about 50% GTS dose was controlled by diffusion, due to the high water solubility of this drug, accompanied by weak drug–PEO interactions. In this case the residence time of drug in the precorneal area is expected to be significantly shorter than that of the PEO carrier.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

A study of release mechanisms of different ophthal...

on European Journal of Pharmaceut... September 2002

Effect of chitosan on in vitro release and ocular...

on International Journal of Pharm... Nov 06, 2002

Effect of chitosan on in vitro release and ocular...

on International Journal of Pharm... Jan 01, 2002

Relevance of polymer molecular weight to the in vi...

on International Journal of Pharm... Jan 01, 2001
More articles like this..